FLNA
FILANA THERAPEUTICS, INC.
+0.03 (+4.15%)0.71USD135K成交股數34.2M市值–本益比(近四季)0.8股價營收比–營收年增(近四季)2026-10-29下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0 · 0 |
| 近 180 天 淨額 | 0 |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2025-11-24 | 11-25 | Anderson Robert Eugene Jr | Director | P 公開市場買進 | 8.6K | 2.90 | 25K | 8.6K | SEC |
| 2025-11-20 | 11-24 | Barry Richard | President & CEO | P 公開市場買進 | 150K | 2.76 | 414K | 938K | SEC |
| 2025-11-19 | 11-20 | Barry Richard | President & CEO | P 公開市場買進 | 73.4K | 2.75 | 202K | 788K | SEC |
| 2025-09-30 | 10-02 | Cook Robert Christopher | Chief Operating & Legal Office | P 公開市場買進 | 13.7K | 2.91 | 40K | 13.7K | SEC |
| 2025-09-22 | 09-23 | Barry Richard | President & CEO | P 公開市場買進 | 7.2K | 2.28 | 16K | 715K | SEC |
| 2025-09-19 | 09-22 | Barry Richard | President & CEO | P 公開市場買進 | 400 | 2.25 | 900.00 | 661K | SEC |
| 2025-09-19 | 09-22 | Barry Richard | President & CEO | P 公開市場買進 | 46.9K | 2.29 | 107K | 708K | SEC |
| 2025-09-18 | 09-22 | Barry Richard | President & CEO | P 公開市場買進 | 185K | 2.24 | 415K | 660K | SEC |
| 2025-09-18 | 09-22 | Barry Richard | President & CEO | P 公開市場買進 | 5.4K | 2.13 | 12K | 475K | SEC |
| 2024-11-29 | 12-03 | Schoen Eric | Chief Financial Officer | S 公開市場賣出 | 59.8K | 3.86 | 231K | 11.5K | SEC |
| 2024-11-29 | 12-03 | Schoen Eric | Chief Financial Officer | M 選擇權執行 | 50.0K | 1.18 | 59K | 71.3K | SEC |
| 2024-11-29 | 12-03 | Kupiec James William | Chief Medical Officer | S 公開市場賣出 | 4.0K | 3.87 | 15K | 0 | SEC |
| 2024-11-29 | 12-03 | Schoen Eric | Chief Financial Officer | S 公開市場賣出 | 2.0K | 3.82 | 8K | 0 | SEC |
| 2024-05-16 | 05-16 | ROBERTSON SANFORD | Director | G 贈與 | 5.0K | – | – | 5.0K | SEC |
| 2024-05-16 | 05-16 | ROBERTSON SANFORD | Director | G 贈與 | 5.0K | – | – | 951K | SEC |
| 2024-04-26 | 04-30 | ROBERTSON SANFORD | Director | M 選擇權執行 | 69.0K | 22.00 | 1.5M | 956K | SEC |
| 2024-04-23 | 04-25 | Barry Richard | Director | M 選擇權執行 | 176K | 22.00 | 3.9M | 470K | SEC |
| 2024-04-18 | 04-22 | Kupiec James William | Chief Medical Officer | M 選擇權執行 | 1.5K | 22.00 | 33K | 4.0K | SEC |
| 2024-04-17 | 04-17 | Schoen Eric | Chief Financial Officer | M 選擇權執行 | 1.5K | 22.00 | 33K | 21.3K | SEC |
| 2023-08-23 | 08-24 | ROBERTSON SANFORD | Director | P 公開市場買進 | 30.0K | 17.45 | 524K | 887K | SEC |
| 2023-08-22 | 08-23 | Barry Richard | Director | P 公開市場買進 | 16.6K | 16.65 | 276K | 293K | SEC |
| 2023-08-21 | 08-23 | Barry Richard | Director | P 公開市場買進 | 1.9K | 16.80 | 32K | 277K | SEC |
| 2023-06-12 | 06-12 | SCANNON PATRICK J MD PHD | Director | M 選擇權執行 | 1.0K | 0.95 | 950.00 | 1.0K | SEC |
| 2023-05-24 | 05-25 | BARBIER REMI | President and CEO | M 選擇權執行 | 14.3K | 16.87 | 241K | 390K | SEC |
| 2023-05-24 | 05-25 | BARBIER REMI | President and CEO | F 繳稅扣股 | 9.5K | 25.25 | 241K | 381K | SEC |
| 2023-05-24 | 05-25 | BARBIER REMI | President and CEO | F 繳稅扣股 | 47.7K | 25.25 | 1.2M | 734K | SEC |
| 2023-05-24 | 05-25 | BARBIER REMI | President and CEO | M 選擇權執行 | 71.4K | 16.87 | 1.2M | 782K | SEC |
| 2023-05-10 | 05-10 | ROBERTSON SANFORD | Director | M 選擇權執行 | 2.1K | 16.66 | 36K | 857K | SEC |
| 2023-05-10 | 05-10 | ROBERTSON SANFORD | Director | M 選擇權執行 | 3.6K | 16.66 | 59K | 855K | SEC |
| 2023-05-10 | 05-10 | ROBERTSON SANFORD | Director | M 選擇權執行 | 3.6K | 19.60 | 70K | 851K | SEC |
| 2023-05-01 | 05-02 | GUSSIN ROBERT Z | Director | M 選擇權執行 | 2.1K | 16.66 | 36K | 10.6K | SEC |
| 2023-05-01 | 05-02 | GUSSIN ROBERT Z | Director | M 選擇權執行 | 3.6K | 16.66 | 59K | 14.1K | SEC |
| 2023-05-01 | 05-02 | GUSSIN ROBERT Z | Director | F 繳稅扣股 | 7.1K | 23.34 | 165K | 10.6K | SEC |
| 2023-05-01 | 05-02 | GUSSIN ROBERT Z | Director | M 選擇權執行 | 3.6K | 19.60 | 70K | 17.7K | SEC |
| 2023-03-07 | 03-08 | Barry Richard | Director | P 公開市場買進 | 77.3K | 25.76 | 2.0M | 275K | SEC |
| 2023-03-07 | 03-08 | O DONNELL MICHAEL J | Director | F 繳稅扣股 | 2.8K | 25.20 | 70K | 6.9K | SEC |
| 2023-03-07 | 03-08 | O DONNELL MICHAEL J | Director | F 繳稅扣股 | 2.4K | 25.20 | 59K | 9.7K | SEC |
| 2023-03-07 | 03-08 | O DONNELL MICHAEL J | Director | M 選擇權執行 | 3.6K | 19.60 | 70K | 12.0K | SEC |
| 2023-03-07 | 03-08 | O DONNELL MICHAEL J | Director | M 選擇權執行 | 3.6K | 16.66 | 59K | 8.4K | SEC |
| 2023-03-06 | 03-08 | Barry Richard | Director | P 公開市場買進 | 11.6K | 26.13 | 302K | 198K | SEC |
| 2022-10-03 | 10-03 | FRIEDMANN NADAV | Chief Medical Officer | M 選擇權執行 | 9.4K | 0.95 | 9K | 79.9K | SEC |
| 2022-09-08 | 09-12 | ROBERTSON SANFORD | Director | M 選擇權執行 | 2.8K | 23.59 | 66K | 1.0M | SEC |
| 2022-08-23 | 08-25 | Barry Richard | Director | P 公開市場買進 | 36.2K | 23.79 | 860K | 186K | SEC |
| 2022-08-23 | 08-24 | Kupiec James William | Chief Clinical Dev. Officer | P 公開市場買進 | 2.5K | 24.44 | 61K | 2.5K | SEC |
| 2022-08-12 | 08-16 | Schoen Eric | Chief Financial Officer | P 公開市場買進 | 2.5K | 19.95 | 50K | 19.8K | SEC |
| 2022-08-12 | 08-16 | ROBERTSON SANFORD | Director | P 公開市場買進 | 100K | 20.69 | 2.1M | 1.0M | SEC |
| 2022-06-07 | 02-07 | BARBIER REMI | President and CEO | J 其他 | 57.1K | – | – | 711K | SEC |
| 2022-06-06 | 06-07 | BARBIER REMI | President and CEO | M 選擇權執行 | 65.4K | 23.38 | 1.5M | 822K | SEC |
| 2022-06-06 | 06-07 | BARBIER REMI | President and CEO | F 繳稅扣股 | 54.7K | 27.93 | 1.5M | 768K | SEC |
| 2022-05-27 | 05-31 | FRIEDMANN NADAV | Chief Medical Officer | F 繳稅扣股 | 21.5K | 26.66 | 573K | 70.5K | SEC |
| 2022-05-27 | 05-31 | FRIEDMANN NADAV | Chief Medical Officer | F 繳稅扣股 | 3.1K | 26.66 | 82K | 92.0K | SEC |
| 2022-05-27 | 05-31 | FRIEDMANN NADAV | Chief Medical Officer | M 選擇權執行 | 24.5K | 23.38 | 573K | 95.1K | SEC |
| 2022-05-27 | 05-31 | FRIEDMANN NADAV | Chief Medical Officer | M 選擇權執行 | 3.5K | 23.38 | 82K | 70.6K | SEC |
| 2022-04-25 | 04-25 | BARBIER REMI | President and CEO | M 選擇權執行 | 4.7K | 16.31 | 76K | 376K | SEC |
| 2022-04-25 | 04-25 | BARBIER REMI | President and CEO | M 選擇權執行 | 44.8K | 0.95 | 43K | 371K | SEC |
| 2022-03-29 | 03-29 | GUSSIN ROBERT Z | Director | M 選擇權執行 | 4.7K | 20.30 | 95K | 9.6K | SEC |
| 2022-03-29 | 03-29 | GUSSIN ROBERT Z | Director | F 繳稅扣股 | 4.0K | 39.98 | 161K | 8.4K | SEC |
| 2022-03-29 | 03-29 | GUSSIN ROBERT Z | Director | M 選擇權執行 | 2.8K | 23.59 | 66K | 12.4K | SEC |
| 2022-03-25 | 03-28 | ROBERTSON SANFORD | Director | M 選擇權執行 | 4.7K | 20.30 | 95K | 925K | SEC |
| 2022-03-15 | 01-03 | FRIEDMANN NADAV | Chief Medical Officer | G 贈與 | 990 | – | – | 78.9K | SEC |
| 2022-01-31 | 01-03 | FRIEDMANN NADAV | Chief Medical Officer | G 贈與 | 10 | – | – | 79.9K | SEC |
| 2021-09-15 | 09-21 | GUSSIN ROBERT Z | Director | M 選擇權執行 | 2.8K | 27.37 | 77K | 6.7K | SEC |
| 2021-09-15 | 09-21 | GUSSIN ROBERT Z | Director | F 繳稅扣股 | 1.7K | 43.92 | 77K | 5.0K | SEC |
| 2021-08-05 | 02-03 | Schoen Eric | Chief Financial Officer | G 贈與 | 8.0K | – | – | 17.3K | SEC |
| 2021-07-20 | 07-20 | BARBIER REMI | President and CEO | M 選擇權執行 | 2.8K | 20.23 | 57K | 327K | SEC |
| 2021-05-27 | 05-28 | BARBIER REMI | President and CEO | F 繳稅扣股 | 54.0K | 55.60 | 3.0M | 1.1M | SEC |
| 2021-05-27 | 05-28 | BARBIER REMI | President and CEO | M 選擇權執行 | 56.0K | 53.55 | 3.0M | 1.1M | SEC |
| 2021-03-30 | 03-31 | ROBERTSON SANFORD | Director | M 選擇權執行 | 2.8K | 27.37 | 77K | 915K | SEC |
| 2021-03-30 | 03-31 | ROBERTSON SANFORD | Director | M 選擇權執行 | 4.7K | 49.00 | 229K | 920K | SEC |
| 2021-03-24 | 02-03 | FRIEDMANN NADAV | Chief Medical Officer | G 贈與 | 1.2K | – | – | 67.1K | SEC |
| 2021-03-17 | 03-18 | FRIEDMANN NADAV | Chief Medical Officer | M 選擇權執行 | 28.0K | 53.55 | 1.5M | 92.4K | SEC |
| 2021-03-17 | 03-18 | FRIEDMANN NADAV | Chief Medical Officer | F 繳稅扣股 | 24.0K | 62.52 | 1.5M | 68.4K | SEC |
| 2021-03-16 | 03-18 | O DONNELL MICHAEL J | Director | F 繳稅扣股 | 4.4K | 52.16 | 229K | 4.9K | SEC |
| 2021-03-16 | 03-18 | O DONNELL MICHAEL J | Director | M 選擇權執行 | 4.7K | 49.00 | 229K | 9.3K | SEC |
| 2020-09-24 | 09-24 | BARBIER REMI | President and CEO | P 公開市場買進 | 10.0K | 9.59 | 96K | 1.1M | SEC |
| 2020-09-18 | 09-21 | ROBERTSON SANFORD | Director | P 公開市場買進 | 36.3K | 8.92 | 324K | 913K | SEC |
| 2020-09-17 | 09-17 | Schoen Eric | Chief Financial Officer | P 公開市場買進 | 10.0K | 7.03 | 70K | 25.3K | SEC |
| 2020-09-17 | 09-17 | Schoen Eric | Chief Financial Officer | P 公開市場買進 | 2.0K | 7.04 | 14K | 27.3K | SEC |
| 2020-09-17 | 09-17 | ROBERTSON SANFORD | Director | P 公開市場買進 | 214K | 6.98 | 1.5M | 876K | SEC |
| 2019-12-31 | 12-31 | BARBIER REMI | President and CEO | P 公開市場買進 | 100K | 5.53 | 553K | 1.1M | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 2.0M | 2.4M | +44.0K (+2%) | 加碼 |
| Two Sigma TWO SIGMA INVESTMENTS, LP | 1.7M | 2.0M | −277K (-14%) | 減碼 |
| MARSHALL WACE, LLP | 1.6M | 1.9M | −415K (-21%) | 減碼 |
| BlackRock, Inc. | 1.5M | 1.7M | +39.0K (+3%) | 加碼 |
| GOLDMAN SACHS GROUP INC | 669K | 796K | +627K (+1518%) | 加碼 |
| GEODE CAPITAL MANAGEMENT, LLC | 616K | 733K | +19.3K (+3%) | 加碼 |
| 德劭 D. E. Shaw & Co., Inc. | 485K | 577K | −74.2K (-13%) | 減碼 |
| GMT Capital Corp | 450K | 536K | 不變 | 持平 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 390K | 464K | +62.8K (+19%) | 加碼 |
| Squarepoint Ops LLC | 318K | 379K | 新進 | 新進 |
| VANGUARD FIDUCIARY TRUST CO | 316K | 376K | +42.0K (+15%) | 加碼 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 292K | 348K | −155K (-35%) | 減碼 |
| GROUP ONE TRADING LLC | 244K | 290K | −58.6K (-19%) | 減碼 |
| STATE STREET CORP | 209K | 249K | −30.9K (-13%) | 減碼 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 133K | 158K | −96 (-0%) | 減碼 |
| Connor, Clark & Lunn Investment Management Ltd. | 132K | 157K | −4.6K (-3%) | 減碼 |
| FEDERATED HERMES, INC. | 120K | 143K | +4.9K (+4%) | 加碼 |
| NORTHERN TRUST CORP | 114K | 136K | −34.9K (-23%) | 減碼 |
| SIMPLEX TRADING, LLC | 99.9K | 119K | −40.1K (-29%) | 減碼 |
| STIFEL FINANCIAL CORP | 75.0K | 89K | 新進 | 新進 |
| XTX Topco Ltd | 64.6K | 77K | +31.3K (+94%) | 加碼 |
| JANE STREET GROUP, LLC | 59.0K | 70K | −166K (-74%) | 減碼 |
| Verition Fund Management LLC | 46.9K | 56K | +8.7K (+23%) | 加碼 |
| LPL Financial LLC | 40.2K | 48K | −821 (-2%) | 減碼 |
| UBS Group AG | 39.1K | 46K | +27.5K (+237%) | 加碼 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 85 -16 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 8 / 24 / 21 / 30 |
| 機構合計持股 · 佔流通股 | 12.7M · 26.2% |
| 合計季末市值 | 14.3M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 6.3M |
|---|---|
| 與上期比 | -0.3% |
| 佔流通股數 | 13.03% |
| 日均成交量 | 193K |
| 回補天數 | 32.7 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 6.3M | -0.3% | 13.03% | 193K | 32.7 |
| 2026-08-14 | 6.3M | -2.3% | 13.06% | 340K | 18.6 |
| 2026-07-31 | 6.5M | +3.6% | 13.37% | 312K | 20.7 |
| 2026-07-15 | 6.2M | -3.9% | 12.91% | 422K | 14.8 |
| 2026-06-30 | 6.5M | -1.3% | 13.43% | 321K | 20.2 |
| 2026-06-15 | 6.6M | -4.5% | 13.61% | 330K | 19.9 |
| 2026-05-29 | 6.9M | +2.9% | 14.25% | 410K | 16.8 |
| 2026-05-15 | 6.7M | -2.3% | 13.85% | 456K | 14.7 |
| 2026-04-30 | 6.8M | -1.1% | 14.17% | 413K | 16.6 |
| 2026-04-15 | 6.9M | -4.3% | 14.34% | 309K | 22.4 |
| 2026-03-31 | 7.2M | -1.0% | 14.99% | 406K | 17.8 |
| 2026-03-13 | 7.3M | +5.1% | 15.14% | 814K | 9.0 |
| 2019-03-29 | 2.0K | +100.0% | 0.00% | 400 | 5.0 |